IMNM earnings: a positive outcome, +10.4%

On May 12, 2022, Immunome Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.4% in the window around the event. It had already run -42.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.